Evidence map›Paper›PMID 42724235›Full record

ArticleCirculation reports2026

Regional Myocardial Tissue Characterization by Cardiac Magnetic Resonance Is Associated With Heart Failure Development in Asymptomatic Transthyretin Amyloid Cardiomyopathy.

Toshihiro Tsuruda, Hiroshi Nakada, Yosuke Suiko, Yunosuke Matsuura, Soichi Komaki, Kohei Moribayashi, Hiroki Tanaka, Masashi Yamaguchi, Kinuko Yamamoto, Takeshi Ideguchi and 10 more

Abstract read
In one paragraph

Article in Circulation reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Toshihiro TsurudaDepartment of Hemo-Vascular Advanced Medicine, Cardiorenal Research Laboratory, Faculty of Medicine, University of Miyazaki Miyazaki Japan.
Hiroshi NakadaDepartment of Radiology, Faculty of Medicine, University of Miyazaki Miyazaki Japan.
Yosuke SuikoDepartment of Internal Medicine, Division of Cardiovascular Medicine and Nephrology, Faculty of Medicine, University of Miyazaki Miyazaki Japan.
Yunosuke MatsuuraDepartment of Internal Medicine, Division of Cardiovascular Medicine and Nephrology, Faculty of Medicine, University of Miyazaki Miyazaki Japan.
Soichi KomakiDepartment of Internal Medicine, Division of Cardiovascular Medicine and Nephrology, Faculty of Medicine, University of Miyazaki Miyazaki Japan.
Kohei MoribayashiDepartment of Internal Medicine, Division of Cardiovascular Medicine and Nephrology, Faculty of Medicine, University of Miyazaki Miyazaki Japan.
Hiroki TanakaDepartment of Internal Medicine, Division of Cardiovascular Medicine and Nephrology, Faculty of Medicine, University of Miyazaki Miyazaki Japan.
Masashi YamaguchiDepartment of Internal Medicine, Division of Cardiovascular Medicine and Nephrology, Faculty of Medicine, University of Miyazaki Miyazaki Japan.
Kinuko YamamotoDepartment of Internal Medicine, Division of Cardiovascular Medicine and Nephrology, Faculty of Medicine, University of Miyazaki Miyazaki Japan.
Takeshi IdeguchiDepartment of Internal Medicine, Division of Cardiovascular Medicine and Nephrology, Faculty of Medicine, University of Miyazaki Miyazaki Japan.
Miyuki OgataHeart Center, University of Miyazaki Hospital Miyazaki Japan.
Miyo TanakaHeart Center, University of Miyazaki Hospital Miyazaki Japan.
Tamasa TeradaDepartment of Radiology, Faculty of Medicine, University of Miyazaki Miyazaki Japan.
Masatsugu KawanoDepartment of Radiology, Faculty of Medicine, University of Miyazaki Miyazaki Japan.
Tomomi OtaDepartment of Medicine of Sensory and Motor Organs, Division of Orthopaedic Surgery, Faculty of Medicine, University of Miyazaki Miyazaki Japan.
Atsushi YamashitaDepartment of Pathology, Faculty of Medicine, University of Miyazaki Miyazaki Japan.
Keisuke YamamotoDepartment of Cardiology, Miyazaki Medical Association Hospital Miyazaki Japan.
Kensaku NishihiraDepartment of Cardiology, Miyazaki Medical Association Hospital Miyazaki Japan.
Yoshisato ShibataDepartment of Cardiology, Miyazaki Medical Association Hospital Miyazaki Japan.
Koichi KaikitaDepartment of Internal Medicine, Division of Cardiovascular Medicine and Nephrology, Faculty of Medicine, University of Miyazaki Miyazaki Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Because the number of asymptomatic individuals diagnosed with transthyretin amyloid cardiomyopathy (ATTR-CM) has been rising, it is important to identify myocardial tissue characteristics associated with heart failure (HF) development in asymptomatic patients with ATTR-CM. Methods and Results: Among 113 patients with ATTR-CM, 14 were asymptomatic (mean age 75±6 years; 79% male) and underwent echocardiography and cardiac magnetic resonance imaging (CMR). Over a median follow-up of 770 days, 6 patients developed HF. Compared with those who remained asymptomatic, these patients had a higher left ventricular mass index (LVMI) on echocardiography (P=0.020). On CMR, native T1 was significantly higher at the basal inferior (P=0.0277) and inferolateral (P=0.0017) segments, whereas the extracellular volume (ECV) fraction was significantly higher at the basal inferolateral (P=0.0296) and anterolateral (P=0.0092) segments. LVMI correlated with native T1 (r=0.599, P=0.024) and ECV at the basal inferolateral (r=0.780, P<0.001) and anterolateral (r=0.624, P=0.017) segments. Kaplan-Meier analysis showed that patients with higher LVMI, native T1 at the basal inferolateral segment, and ECV at the basal anterolateral segment had a higher incidence of HF development. Conclusions: In asymptomatic ATTR-CM patients, HF development was associated with increased LVMI and regional myocardial tissue abnormalities in the basal lateral wall detected by native T1 and ECV on CMR; however, these findings should be considered exploratory and require validation in larger studies.

Indexed as

Extracellular volume fractionHeart failureLeft ventricular mass indexNative T1 mappingSegmental analysis

Identifiers

PMID42724235
PMCPMC13558264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.